CHLORPROMAZINE vs piperacetazine
Costs · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Findings
What do systematic reviews say?
26 questions · 26 findings · 12 reviews · Schizophrenia
No studies found 9 · 34.6%GRADE not reported 16 · 61.5%Very low 0 · 0%Low 1 · 3.8%Moderate 0 · 0%High 0 · 0%
Glycerol laxative vs tuina massage
Costs · antipsychotic‐related constipation
The review found no eligible studies for this question.
1 finding from 1 review
- Pharmacological treatment for antipsychotic‐related constipation 2017 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Glycerol laxative vs acupuncture
Costs · antipsychotic‐related constipation
The review found no eligible studies for this question.
1 finding from 1 review
- Pharmacological treatment for antipsychotic‐related constipation 2017 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Mannitol vs phenolphthalein or rhubarb soda
Costs · antipsychotic‐related constipation
The review found no eligible studies for this question.
1 finding from 1 review
- Pharmacological treatment for antipsychotic‐related constipation 2017 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
ASENAPINE vs placebo
Costs · adults with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Droperidol vs haloperidol
Economic: direct costs · acute psychosis
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Droperidol vs midazolam
Economic: direct costs · acute psychosis
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Droperidol vs OLANZAPINE
Economic: direct costs · acute psychosis
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Droperidol vs placebo
Economic: direct costs · acute psychosis
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
HALOPERIDOL + PROMETHAZINE vs ZIPRASIDONE
Economic outcomes: Cost of care · people with psychosis‐induced aggression
1 finding from 1 review
- Haloperidol plus promethazine for psychosis‐induced aggression 2016 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
HALOPERIDOL + PROMETHAZINE vs ANTIPSYCHOTIC & BENZODIAZEPINE ‐ HALOPERIDOL + MIDAZOLAM
Economic outcomes: Cost of care · people with psychosis‐induced aggression
1 finding from 1 review
- Haloperidol plus promethazine for psychosis‐induced aggression 2016 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
HALOPERIDOL + PROMETHAZINE vs lorazepam
Economic outcomes: Cost of care · people with psychosis‐induced aggression
1 finding from 1 review
- Haloperidol plus promethazine for psychosis‐induced aggression 2016 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
HALOPERIDOL + PROMETHAZINE vs midazolam
Economic outcomes: Cost of care · people with psychosis‐induced aggression
1 finding from 1 review
- Haloperidol plus promethazine for psychosis‐induced aggression 2016 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
HALOPERIDOL + PROMETHAZINE vs haloperidol
Economic outcomes: Cost of care · people with psychosis‐induced aggression
1 finding from 1 review
- Haloperidol plus promethazine for psychosis‐induced aggression 2016 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
HALOPERIDOL + PROMETHAZINE vs OLANZAPINE
Economic outcomes: Cost of care · people with psychosis‐induced aggression
1 finding from 1 review
- Haloperidol plus promethazine for psychosis‐induced aggression 2016 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
α‐FLUPENTHIXOL vs PLACEBO or β‐FLUPENTHIXOL
Economic: direct costs · patients with schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Physical health monitoring vs No monitoring
Economic: Increased costs of health care · people with severe mental disorders
1 finding from 1 review
- Physical health care monitoring for people with serious mental illness 2014 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
Educational intervention with information and practical components (theoretical oral health education plus practical skills training) for nursing staff and/or residents vs usual care
Economic: Increased costs of health care · People with serious mental illness (all included participants had schizophrenia); majority aged 18 to 65 years per NIMH 1987, or with…
The review found no eligible studies for this question.
1 finding from 1 review
- Oral health education (advice and training) for people with serious mental illness 2016 · Cochrane All outcomesno estimate extracted0 studiesNo studies found
Peer support plus standard care vs clinician‐led support plus standard care
Economic: indirect costs (cost to society) · people with schizophrenia or other serious mental illness
The review found no eligible studies for this question.
1 finding from 1 review
- Peer support for people with schizophrenia or other serious mental illness 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Peer support plus standard care vs usual care
Economic: indirect costs (cost to society) · people with schizophrenia or other serious mental illness
The review found no eligible studies for this question.
1 finding from 1 review
- Peer support for people with schizophrenia or other serious mental illness 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found